Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Director | Common Stock | 1K | $185K | $185.32 | Apr 1, 2022 | Direct |
Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | Mar 18, 2024 | Direct |
Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | Mar 18, 2024 | Jann E. Paul GRAT III |
Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | Mar 18, 2024 | Jann E Paul Revocable Trust |
Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | Mar 18, 2024 | Steve M. Paul Family 2021 Delaware Trust |
Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | Mar 18, 2024 | Steven M. Paul Family 2024 Trust |
Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | Mar 18, 2024 | The Steven M Paul Revocable Trust |
Karuna Therapeutics, Inc. | Director | Option (right to buy) | 0 | $0 | $142.74 | Mar 18, 2024 | Direct |
Rapport Therapeutics, Inc. | Director | Common Stock | 478K | Jun 6, 2024 | Direct | ||
Voyager Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15K | Jun 3, 2021 | Direct | ||
Sage Therapeutics, Inc. | Director | Stock Options (Right to buy) | 3.97K | Jan 3, 2024 | Direct | ||
ALNYLAM PHARMACEUTICALS, INC. | Director | Non-Qualified Stock Option (right to buy) | 0 | Apr 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RAPP | Rapport Therapeutics, Inc. | Jun 6, 2024 | 0 | $0 | 3 | Jun 6, 2024 | Director |
KRTX | Karuna Therapeutics, Inc. | Mar 18, 2024 | 18 | -$830M | 4 | Mar 18, 2024 | Director |
KRTX | Karuna Therapeutics, Inc. | Feb 29, 2024 | 7 | $14.9M | 4 | Mar 4, 2024 | Director |
KRTX | Karuna Therapeutics, Inc. | Feb 23, 2024 | 4 | $600K | 4 | Feb 26, 2024 | Director |
KRTX | Karuna Therapeutics, Inc. | Feb 9, 2024 | 1 | -$255K | 4 | Feb 12, 2024 | Director |
SAGE | Sage Therapeutics, Inc. | Jan 3, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
SAGE | Sage Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
KRTX | Karuna Therapeutics, Inc. | Feb 9, 2023 | 6 | $0 | 4 | Feb 13, 2023 | CSO and President of R&D, Director |
SAGE | Sage Therapeutics, Inc. | Jan 4, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
SAGE | Sage Therapeutics, Inc. | Nov 28, 2022 | 1 | $191 | 4 | Nov 30, 2022 | Director |
SAGE | Sage Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
ALNY | ALNYLAM PHARMACEUTICALS, INC. | Apr 1, 2022 | 12 | -$2.39M | 4 | Apr 5, 2022 | Director |
KRTX | Karuna Therapeutics, Inc. | Feb 16, 2022 | 1 | $0 | 4 | Feb 17, 2022 | President & CEO, Director |
SAGE | Sage Therapeutics, Inc. | Jan 4, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
SAGE | Sage Therapeutics, Inc. | Nov 9, 2021 | 1 | $43.40 | 4 | Nov 12, 2021 | Director |
KRTX | Karuna Therapeutics, Inc. | Aug 17, 2021 | 2 | $250K | 4 | Aug 18, 2021 | PRESIDENT & CEO, Director |
ALNY | ALNYLAM PHARMACEUTICALS, INC. | Jul 15, 2021 | 1 | $0 | 4 | Jul 19, 2021 | Director |
SAGE | Sage Therapeutics, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |
VYGR | Voyager Therapeutics, Inc. | Jun 3, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |